Christine Hauser

1.2k total citations
22 papers, 756 citations indexed

About

Christine Hauser is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christine Hauser has authored 22 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christine Hauser's work include Cancer Genomics and Diagnostics (7 papers), Prostate Cancer Treatment and Research (7 papers) and Protein Tyrosine Phosphatases (5 papers). Christine Hauser is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Prostate Cancer Treatment and Research (7 papers) and Protein Tyrosine Phosphatases (5 papers). Christine Hauser collaborates with scholars based in Australia, United States and Switzerland. Christine Hauser's co-authors include Tony Tiganis, Benjamin G. Neel, Sandra Galić, Barbara B. Kahn, Fawaz G. Haj, Nicholas K. Tonks, Patricia Bukczynska, Florian Wiede, Ben Shields and Naomi W. Court and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer Cell.

In The Last Decade

Christine Hauser

21 papers receiving 738 citations

Peers

Christine Hauser
Daniel Bulut Germany
B. Moseley Waite United States
Laura W. Bowers United States
Christine Hauser
Citations per year, relative to Christine Hauser Christine Hauser (= 1×) peers Dongmei Song

Countries citing papers authored by Christine Hauser

Since Specialization
Citations

This map shows the geographic impact of Christine Hauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Hauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Hauser more than expected).

Fields of papers citing papers by Christine Hauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Hauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Hauser. The network helps show where Christine Hauser may publish in the future.

Co-authorship network of co-authors of Christine Hauser

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Hauser. A scholar is included among the top collaborators of Christine Hauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Hauser. Christine Hauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hauser, Christine, Patricia Bukczynska, Nicole Ng, et al.. (2021). Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer. Asia-Pacific Journal of Clinical Oncology. 17. 1 indexed citations
2.
Crumbaker, Megan, Andrew O. Yam, Andrew Nguyen, et al.. (2021). 177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial. Journal of Nuclear Medicine. 63(4). 560–566. 31 indexed citations
3.
Fettke, Heidi, Edmond M. Kwan, Patricia Bukczynska, et al.. (2021). Independent prognostic impact of plasma NCOA2 alterations in metastatic castration‐resistant prostate cancer. The Prostate. 81(13). 992–1001. 7 indexed citations
4.
Fettke, Heidi, Jason A. Steen, Edmond M. Kwan, et al.. (2020). Analytical Validation of an Error-Corrected Ultra-Sensitive Ctdna Next-Generation Sequencing Assay. BioTechniques. 69(2). 133–140. 5 indexed citations
5.
Fettke, Heidi, Edmond M. Kwan, Patricia Bukczynska, et al.. (2020). Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor–treated Metastatic Castration-resistant Prostate Cancer. European Urology Focus. 7(6). 1287–1291. 13 indexed citations
6.
Fettke, Heidi, Edmond M. Kwan, Maria Docanto, et al.. (2020). Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer. European Urology. 78(2). 173–180. 44 indexed citations
7.
Kwan, Edmond M., Heidi Fettke, Patricia Bukczynska, et al.. (2020). Plasma cell-free DNA (cfDNA) profiling of copy number variation (CNV) to identify poor prognostic biomarkers in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(6_suppl). 176–176.
8.
Haschke, Manuel, Niccolò Buetti, Christine Hauser, et al.. (2019). Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study. Clinical Microbiology and Infection. 26(3). 333–339. 99 indexed citations
9.
Batliner, Jasmin, Mohammed Abba, Christine Hauser, & Heike Allgayer. (2013). Abstract 4186: miR-218 suppresses invasion and migration via inhibition of ZEB2 and N-Cadherin in colon cancer.. Cancer Research. 73(8_Supplement). 4186–4186. 2 indexed citations
10.
Loh, Kim, Atsushi Fukushima, Xinmei Zhang, et al.. (2012). Elevated Hypothalamic TCPTP in Obesity Contributes to Cellular Leptin Resistance. Cell Metabolism. 15(6). 925–926. 4 indexed citations
11.
Shields, Benjamin J., Florian Wiede, Esteban N. Gurzov, et al.. (2012). TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers. Molecular and Cellular Biology. 33(3). 557–570. 77 indexed citations
12.
Loh, Kim, Atsushi Fukushima, Xinmei Zhang, et al.. (2011). Elevated Hypothalamic TCPTP in Obesity Contributes to Cellular Leptin Resistance. Cell Metabolism. 14(5). 684–699. 154 indexed citations
13.
Hauser, Christine, Andreas Kronbichler, Markus Pirklbauer, et al.. (2011). Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression. American Journal of Physiology-Renal Physiology. 301(5). F1014–F1025. 31 indexed citations
14.
Shields, Ben, Naomi W. Court, Christine Hauser, Patricia Bukczynska, & Tony Tiganis. (2008). Cell cycle-dependent regulation of SFK, JAK1 and STAT3 signaling by the protein tyrosine phosphatase TCPTP. Cell Cycle. 7(21). 3405–3416. 19 indexed citations
15.
Shields, Ben, Christine Hauser, Patricia Bukczynska, Naomi W. Court, & Tony Tiganis. (2008). DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase Progression. Cancer Cell. 14(2). 166–179. 46 indexed citations
16.
Galić, Sandra, Christine Hauser, Barbara B. Kahn, et al.. (2005). Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP. Molecular and Cellular Biology. 25(2). 819–829. 176 indexed citations
17.
Wermke, Kathleen, Christine Hauser, G. Komposch, & Angelika Stellzig. (2002). Spectral Analysis of Prespeech Sounds (Spontaneous Cries) in Infants With Unilateral Cleft Lip and Palate (UCLP): A Pilot Study. The Cleft Palate-Craniofacial Journal. 39(3). 285–294. 7 indexed citations
18.
Emonet, Stéphane, Gürkan Kaya, & Christine Hauser. (2000). [Gleich's syndrome].. PubMed. 127(6-7). 616–8. 10 indexed citations
19.
Hauser, Christine, et al.. (2000). Eruption of impacted canines with an Australian helical archwire.. PubMed. 34(9). 538–41. 5 indexed citations
20.
Emonet, Stéphane, et al.. (1998). Ethanol-Induced Urticaria: Elevated Tryptase Levels after Double-Blind, Placebo-Controlled Challenge. Dermatology. 197(2). 181–182. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026